Prognostic evaluation of oral tongue cancer: Means, markers and perspectives (II)

Oral Oncology

Volumn 46, Issue 9, 2010, Pages 636-643

  Bello, Ibrahim O ^a   Soini, Ylermi ^b   Salo, Tuula ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Oral (mobile) tongue cancer; Prognosis; Prognostic factors; Review; Squamous cell carcinoma; Survival

Indexed keywords

BAG 1 PROTEIN; BASIC FIBROBLAST GROWTH FACTOR; BETA CATENIN; CARBONATE DEHYDRATASE; CD34 ANTIGEN; CELL NUCLEUS DNA; CLAUDIN; CYCLIN B1; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL CELL ADHESION MOLECULE; ERYTHROPOIETIN RECEPTOR; GLUCOSE TRANSPORTER; HYPOXIA INDUCIBLE FACTOR 1; INTEGRIN; KI 67 ANTIGEN; MASPIN; MATRIX METALLOPROTEINASE; OCCLUDIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P14; PROTEIN P16; PROTEIN P21; PROTEIN P27; TUMOR MARKER; UVOMORULIN; VASCULOTROPIN;

APOPTOSIS; BLOOD ANALYSIS; BLOOD SAMPLING; CANCER GROWTH; CANCER INVASION; CANCER RISK; CANCER STAGING; DNA CONTENT; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; ORAL TONGUE SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SALIVA ANALYSIS; TONGUE CARCINOMA; TUMOR MICROENVIRONMENT; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TONGUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77956394234     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2010.06.008     Document Type: Review

References (131)

1. T. Asakage, T. Yokose, K. Mukai, S. Tsugane, Y. Tsubono, and M. Asai Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue Cancer 82 8 1998 1443 1448
2. A.P.W. Yuen, K.Y. Lam, L.K. Lam, C.M. Ho, A. Wong, and T.L. Chow Prognostic factors of clinically stage I and II oral tongue carcinoma - a comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features Head Neck 24 2002 513 520
3. J. Jung, N.H. Cho, J. Kim, E.C. Choi, S.Y. Lee, and H.K. Byeon Significant invasion depth of early oral tongue cancer originated from the lateral border to predict regional metastases and prognosis Int J Oral Maxillofac Surg 38 6 2009 653 660
4. B. Brown, L. Barnes, J. Mazariegos, F. Taylor, J. Johnson, and R.L. Wagner Prognostic factors in mobile tongue and floor of mouth carcinoma Cancer 64 6 1989 1195 1202
5. A. Nathanson, K. Agren, A. Biorklund, M.G. Lind, L. Andreason, and M. Anniko Evaluation of some prognostic factors in small squamous cell carcinoma of the mobile tongue: a multicenter study in Sweden Head Neck 11 5 1989 387 392
6. J.T. Korpi, V. Kervinen, H. Maklin, A. Vaananen, M. Lahtinen, and E. Laara Collagenase-2 (matrix metalloproteinase-8) plays a protective role in tongue cancer Br J Cancer 98 4 2008 766 775
7. G. Teixeira, L. Antonangelo, L. Kowalski, P. Saldiva, A. Ferraz, and G. Silva Filho Argyrophilic nucleolar organizer regions staining is useful in predicting recurrence-free interval in oral tongue and floor of mouth squamous cell carcinoma Am J Surg 172 6 1996 684 688
8. S.H. Huang, D. Hwang, G. Lockwood, D.P. Goldstein, and B. O'Sullivan Predictive value of tumor thickness for cervical lymph node involvement in squamous cell carcinoma of the oral cavity. A meta-analysis of reported studies Cancer 115 7 2009 1489 1497
9. P. Lam, K.M. Au-Yeung, P.W. Cheng, W.I. Wei, A.P. Yuen, and N. Trendell-Smith Correlating MRI and histologic tumor thickness in the assessment of oral tongue cancer AJR Am J Roentgenol 182 3 2004 803 808
10. L. Preda, F. Chiesa, L. Calabrese, A. Latronico, R. Bruschini, and M.E. Leon Relationship between histologic thickness of tongue carcinoma and thickness estimated from preoperative MRI Eur Radiol 16 10 2006 2242 2248
11. M. Okura, S. Iida, T. Aikawa, T. Adachi, N. Yoshimura, and T. Yamada Tumor thickness and paralingual distance of coronal MR imaging predicts cervical node metastases in oral tongue carcinoma AJNR Am J Neuroradiol 29 1 2008 45 50
12. A.C. Broders Squamos-cell epithelioma of the lip J Am Med Assoc 74 1920 656 664
13. M. Okamoto, M. Nishimine, M. Kishi, T. Kirita, M. Sugimura, and M. Nakamura Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue J Oral Pathol Med 31 4 2002 227 233
14. N. Al-Rajhi, Y. Khafaga, J. El-Husseiny, M. Saleem, W. Mourad, and A. Al-Otieschan Early stage carcinoma of oral tongue: prognostic factors for local control and survival Oral Oncol 36 6 2000 508 514
15. P. O-charoenrat, G. Pillai, S. Patel, C. Fisher, D. Archer, and S. Eccles Tumour thickness predicts cervical nodal metastases and survival in early oral tongue cancer Oral Oncol 39 4 2003 386 390
16. J.A. Woolgar Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma Oral Oncol 42 3 2006 229 239
17. J.J. Pindborg, P.A. Reichart, C.J. Smith, and I. Van der Waal Histological typing of cancer and precancer of the oral mucosa 2nd ed. 1997 Springer-Verlag New York
18. Y. Soini, P. Paakko, and V.P. Lehto Histopathological evaluation of apoptosis in cancer Am J Pathol 153 4 1998 1041 1053
19. X. Xie, O.P. Clausen, P. De Angelis, and M. Boysen The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue Cancer 86 6 1999 913 920
20. K.N. Naresh, K. Lakshminarayanan, S.A. Pai, and A.M. Borges Apoptosis index is a predictor of metastatic phenotype in patients with early stage squamous carcinoma of the tongue - a hypothesis to support this paradoxical association Cancer 91 3 2001 578 584
21. J. Hemmer, and J. Kreidler Flow cytometric DNA ploidy analysis of squamous cell carcinoma of the oral cavity. Comparison with clinical staging and histologic grading Cancer 66 2 1990 317 320
22. T. Saito, J. Sato, A. Satoh, K. Notani, H. Fukuda, and S. Mizuno Flow cytometric analysis of nuclear DNA content in tongue squamous cell carcinoma: relation to cervical lymph node metastasis Int J Oral Maxillofac Surg 23 1 1994 28 31
23. L.D. Cooke, T.G. Cooke, G. Forster, D.G. MacDonald, A.G. Robertson, and D.S. Soutar Flow cytometric analysis of DNA content in squamous carcinoma of the tongue: the relationship to host and tumour factors and survival Clin Otolaryngol Allied Sci 19 2 1994 131 134
24. D. Wangsa, M. Ryott, E. Avall-Lundqvist, F. Petersson, G. Elmberger, and J. Luo Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma Br J Cancer 99 7 2008 1121 1128
25. A. Högmo, R. Kuylenstierna, J. Lindholm, and E. Munck-Wikland Predictive value of malignancy grading systems, DNA content, p53, and angiogenesis for stage I tongue carcinomas J Clin Pathol 52 1 1999 35 40
26. R.K. O'Donnell, M. Kupferman, S.J. Wei, S. Singhal, R. Weber, and B. O'Malley Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity Oncogene 24 7 2005 1244 1251
27. P. Roepman, L.F. Wessels, N. Kettelarij, P. Kemmeren, A.J. Miles, and P. Lijnzaad An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas Nat Genet 37 2 2005 182 186
28. C.L. Estilo, P. O-charoenrat, S. Talbot, N.D. Socci, D.L. Carlson, and R. Ghossein BMC Cancer 9 2009 11
29. H. Watanabe, K. Mogushi, M. Miura, R. Yoshimura, T. Kurabayashi, and H. Shibuya Prediction of lymphatic metastasis based on gene expression profile analysis after brachytherapy for early-stage oral tongue carcinoma Radiother Oncol 87 2 2008 237 242
30. L. Dahlgren, H.M. Dahlstrand, D. Lindquist, A. Hogmo, L. Bjornestal, and J. Lindholm Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patients Int J Cancer 112 6 2004 1015 1019
31. J. Mork, A.K. Lie, E. Glattre, G. Hallmans, E. Jellum, and P. Koskela Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck N Engl J Med 344 15 2001 1125 1131
32. C. Scully Oral squamous cell carcinoma; from an hypothesis about a virus, to concern about possible sexual transmission Oral Oncol 38 3 2002 227 234
33. X.H. Liang, J. Lewis, R. Foote, D. Smith, and D. Kademani Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience J Oral Maxillofac Surg 66 9 2008 1875 1880
34. S.J. Talbot, and D.H. Crawford Viruses and tumours-an update Eur J Cancer 40 13 2004 1998 2005
35. J. Pintos, M.J. Black, N. Sadeghi, P. Ghadirian, A.G. Zeitouni, and R.P. Viscidi Human papillomavirus infection and oral cancer: a case-control study in Montreal, Canada Oral Oncol 44 3 2008 242 250
36. G. Campisi, and L. Giovannelli Controversies surrounding human papilloma virus infection, head and neck vs oral cancer, implications for prophylaxis and treatment Head Neck Oncol 1 1 2009 8
37. M.M. Fernandez, A. Garcia-Rozado, and P.L. Parente Is microvascular density an independent prognostic factor in squamous cell carcinoma of the tongue? Acta Otorrinolaringol Esp 58 8 2007 341 346
38. H.C. Chuang, C.Y. Su, H.Y. Huang, C.Y. Chien, C.M. Chen, and C.C. Huang High expression of CD105 as a prognostic predictor of early tongue cancer Laryngoscope 116 7 2006 1175 1179
39. T. Shpitzer, M. Chaimoff, R. Gal, Y. Stern, R. Feinmesser, and K. Segal Tumor angiogenesis as a prognostic factor in early oral tongue cancer Arch Otolaryngol Head Neck Surg 122 8 1996 865 868
40. S. Kantola, M. Parikka, K. Jokinen, K. Hyrynkangs, Y. Soini, and O.P. Alho Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors Br J Cancer 83 5 2000 614 619
41. D.A. Leedy, D.R. Trune, J.D. Kronz, N. Weidner, and J.I. Cohen Tumor angiogenesis, the P53 antigen, and cervical metastasis in squamous cell carcinoma of the tongue Otolaryngol Head Neck Surg 111 4 1994 417 422
42. Y.W. Chen, E.H. Yu, T.H. Wu, W.L. Lo, W.Y. Li, and S.Y. Kao Histopathological factors affecting nodal metastasis in tongue cancer: analysis of 94 patients in Taiwan Int J Oral Maxillofac Surg 37 10 2008 912 916
43. S.D. Silva, D.E. Perez, I.N. Nishimoto, F.A. Alves, C.A. Pinto, and L.P. Kowalski Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings Oral Dis 14 4 2008 376 382
44. A.S. Hosal, O.F. Unal, and A. Ayhan Possible prognostic value of histopathologic parameters in patients with carcinoma of the oral tongue Eur Arch Otorhinolaryngol 255 4 1998 216 219
45. J.N. Myers, T. Elkins, D. Roberts, and R.M. Byers Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes Otolaryngol Head Neck Surg 122 1 2000 44 51
46. A. Sparano, G. Weinstein, A. Chalian, M. Yodul, and R. Weber Multivariate predictors of occult neck metastasis in early oral tongue cancer Otolaryngol Head Neck Surg 131 4 2004 472 476
47. K.A. Kurtz, H.T. Hoffman, B. Zimmerman, and R.A. Robinson Perineural and vascular invasion in oral cavity squamous carcinoma - increased incidence on re-review of slides and by using immunohistochemical enhancement Arch Pathol Lab Med 129 3 2005 354 359
48. K. Almholt, and M. Johnsen Stromal cell involvement in cancer Recent Results Cancer Res 162 2003 31 42
49. B. Muller, B. Fischer, and W. Kreutz An acidic microenvironment impairs the generation of non-major histocompatibility complex-restricted killer cells Immunology 99 3 2000 375 384
50. A.D. Santin Lymph node metastases: the importance of the microenvironment Cancer 88 1 2000 175 179
51. R. Kalluri, and M. Zeisberg Fibroblasts in cancer Nat Rev Cancer 6 5 2006 392 401
52. A. Orimo, and R.A. Weinberg Stromal fibroblasts in cancer: a novel tumor-promoting cell type Cell Cycle 5 15 2006 1597 1601
53. A. Orimo, P.B. Gupta, D.C. Sgroi, F. Arenzana-Seisdedos, T. Delaunay, and R. Naeem Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 121 3 2005 335 348
54. A. Ostman, and M. Augsten Cancer-associated fibroblasts and tumor growth-bystanders turning into key players Curr Opin Genet Dev 19 1 2009 67 73
55. O. De Wever, P. Demetter, M. Mareel, and M. Bracke Stromal myofibroblasts are drivers of invasive cancer growth Int J Cancer 123 10 2008 2229 2238
56. M. Vered, A. Dobriyan, D. Dayan, R. Yahalom, Y.P. Talmi, and L. Bedrin Tumor-host histopathologic variables, stromal myofibroblasts and risk score, are significantly associated with recurrent disease in tongue cancer Cancer Sci 101 1 2010 274 280
57. Vered M, Dayan D, Yahalom R, Dobriyan A, Barshack I, Bello IO, et al. Cancer-associated fibroblasts and epithelial-mesenchymal transition in metastatic oral tongue squamous cell carcinoma. Int J Cancer (in press) doi: 10.1002/ijc.25358.
58. G. Anneroth, J. Batsakis, and M. Luna Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas Scand J Dent Res 95 3 1987 229 249
59. P.A. Jakobsson, C.M. Eneroth, D. Killander, G. Moberger, and B. Mrtensson Histologic classification and grading of malignancy in carcinoma of the larynx Acta Radiol Ther Phys Biol 12 1973 1 8
60. M. Bryne, H.S. Koppang, R. Lilleng, T. Stene, G. Bang, and E. Dabelsteen New malignancy grading is a better prognostic indicator than Broders' grading in oral squamous cell carcinomas J Oral Pathol Med 18 8 1989 432 437
61. E.W. Odell, P. Jani, M. Sherriff, S.M. Ahluwalia, J. Hibbert, and D.A. Levison The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion Cancer 74 3 1994 789 794
62. J.A. Woolgar, and J. Scott Prediction of cervical lymph node metastasis in squamous cell carcinoma of the tongue/floor of mouth Head Neck 17 1995 463 472
63. H. Kurokawa, M. Zhang, S. Matsumoto, Y. Yamashita, T. Tomoyose, and T. Tanaka The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma J Oral Pathol Med 34 6 2005 329 333
64. E.J. Silveira, G.P. Godoy, R.D. Lins, L. Arruda Mde, C.C. Ramos, and A. Freitas Rde Correlation of clinical, histological, and cytokeratin profiles of squamous cell carcinoma of the oral tongue with prognosis Int J Surg Pathol 15 4 2007 376 383
65. M. Weijers, G.B. Snow, P. Dick Bezemer, and I. van der Waal Malignancy grading is no better than conventional histopathological grading in small squamous cell carcinoma of tongue and floor of mouth: retrospective study in 128 patients J Oral Pathol Med 38 4 2009 343 347
66. R.H. Spiro, O. Guillamondegui, A.F. Paulino, and A.G. Huvos Pattern of invasion and margin assessment in patients with oral tongue cancer Head Neck 21 5 1999 408 413
67. T. Sarioglu, T. Yilmaz, A. Sungur, and B. Gursel The effect of lymphocytic infiltration on clinical survival in cancer of the tongue Eur Arch Otorhinolaryngol 251 6 1994 366 369
68. A. Brandwein-Gensler, M.S. Teixeira, C.M. Lewis, B. Lee, L. Rolnitzky, and J.J. Hille Oral squamous cell carcinoma - histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival Am J Surg Pathol 29 2 2005 167 178
69. J.M. Bhatavdekar, D.D. Patel, H.H. Vora, N.G. Shah, P.R. Chikhlikar, and N. Ghosh Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience Head Neck 22 3 2000 257 264
70. X. Li, Z. Qiao, X. Long, J. Wei, and Y. Cheng Serum concentration of AMDL DR-70 for the diagnosis and prognosis of carcinoma of the tongue Br J Oral Maxillofac Surg 43 6 2005 513 515
71. R. Nagler, O. Ben-Izhak, V. Cohen-Kaplan, I. Shafat, I. Vlodavsky, and S. Akrish Heparanase up-regulation in tongue cancer: tissue and saliva analysis Cancer 110 12 2007 2732 2739
72. J.S. Cooper, T.F. Pajak, A.A. Forastiere, J. Jacobs, B.H. Campbell, and S.B. Saxman Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 19 2004 1937 1944
73. J. Bernier, C. Domenge, M. Ozsahin, K. Matuszewska, J.L. Lefebvre, and R.H. Greiner Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 19 2004 1945 1952
74. K.E. Rusthoven, D. Raben, J.I. Song, M. Kane, T.A. Altoos, and C. Chen Survival and patterns of relapse in patients with oral tongue cancer J Oral Maxillofac Surg 68 3 2010 584 589
75. M. Yao, K. Chang, G.F. Funk, H. Lu, H. Tan, and J. Wacha The failure patterns of oral cavity squamous cell carcinoma after intensity-modulated radiotherapy-the University of Iowa experience Int J Radiat Oncol Biol Phys 67 5 2007 1332 1341
76. K. Rusthoven, A. Ballonoff, D. Raben, and C. Chen Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma Cancer 112 2 2008 345 351
77. K.M. Sathyan, R. Sailasree, R. Jayasurya, K. Lakshminarayanan, T. Abraham, and K.R. Nalinakumari Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma J Cancer Res Clin Oncol 132 9 2006 601 609
78. K. Freier, S. Joos, C. Flechtenmacher, F. Devens, A. Benner, and F.X. Bosch Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma Cancer Res 63 6 2003 1179 1182
79. E.E. Ntzani, and J.P. Ioannidis Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment Lancet 362 9394 2003 1439 1444
80. P.A. Kyzas, D. Denaxa-Kyza, and J.P. Ioannidis Almost all articles on cancer prognostic markers report statistically significant results Eur J Cancer 43 17 2007 2559 2579
81. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, and G.M. Clark Reporting recommendations for tumor marker prognostic studies (remark) Exp Oncol 28 2 2006 99 105
82. M.J. Duffy, and J. Crown A personalized approach to cancer treatment: how biomarkers can help Clin Chem 54 11 2008 1770 1779
83. J.J. Hornberg, F.J. Bruggeman, H.V. Westerhoff, and J. Lankelma Cancer: a systems biology disease Biosystems 83 2-3 2006 81 90
84. K. Katoh, Y. Nakanishi, S. Akimoto, K. Yoshimura, M. Takagi, and M. Sakamoto Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue Oncology 62 4 2002 318 326
85. M. Ryott, D. Wangsa, K. Heselmeyer-Haddad, J. Lindholm, G. Elmberger, and G. Auer EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma Eur J Cancer 45 9 2009 1700 1708
86. I.I. Na, H.J. Kang, S.Y. Cho, J.S. Koh, J.K. Lee, and B.C. Lee EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil Eur J Cancer 43 3 2007 520 526
87. D. Ulanovski, Y. Stern, P. Roizman, T. Shpitzer, A. Popovtzer, and R. Feinmesser Expression of EGFR and Cerb-B2 as prognostic factors in cancer of the tongue Oral Oncol 40 5 2004 532 537
88. S.C. Lim, S. Zhang, G. Ishii, Y. Endoh, K. Kodama, and S. Miyamoto Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue Clin Cancer Res 10 1 Pt 1 2004 166 172
89. H. Harada, K. Omura, Y. Nakajima, S. Hasegawa, and S. Mogi Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma J Exp Clin Cancer Res 25 3 2006 351 356
90. K.A. Hassan, A.K. El-Naggar, J.C. Soria, D. Liu, W.K. Hong, and L. Mao Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue Clin Cancer Res 7 8 2001 2458 2462
91. L. Wang, T. Liu, M. Nishioka, R.L. Aguirre, S.S. Win, and N. Okada Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: relationship between clinicopathological appearances and cell proliferation Oral Oncol 42 6 2006 625 631
92. H.H. Vora, N.G. Shah, D.D. Patel, T.I. Trivedi, and P.R. Chikhlikar Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis J Surg Oncol 82 1 2003 34 50
93. H. Goto, K. Kawano, I. Kobayashi, H. Sakai, and S. Yanagisawa Expression of cyclin D1 and GSK-3beta and their predictive value of prognosis in squamous cell carcinomas of the tongue Oral Oncol 38 6 2002 549 556
94. M. Fujii, R. Ishiguro, T. Yamashita, and M. Tashiro Cyclin D1 amplification correlates with early recurrence of squamous cell carcinoma of the tongue Cancer Lett 172 2 2001 187 192
95. H. Mineta, K. Miura, S. Takebayashi, Y. Ueda, K. Misawa, and H. Harada Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma Oral Oncol 36 2 2000 194 198
96. R.J. Bova, D.I. Quinn, J.S. Nankervis, I.E. Cole, B.F. Sheridan, and M.J. Jensen Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue Clin Cancer Res 5 10 1999 2810 2819
97. S. Wada, L. Yue, and I. Furuta Prognostic significance of p34cdc2 expression in tongue squamous cell carcinoma Oral Oncol 40 2 2004 164 169
98. L. Davies, N.J. Hardin, and B.G. Beatty Can Ki-67 predict recurrence of NO squamous cell carcinoma of the tongue? Ann Otol Rhinol Laryngol 115 1 2006 12 17
99. S.D. Silva, D.E. Perez, F.A. Alves, I.N. Nishimoto, C.A. Pinto, and L.P. Kowalski ErbB2 and fatty acid synthase (FAS) expression in 102 squamous cell carcinomas of the tongue: correlation with clinical outcomes Oral Oncol 44 5 2008 484 490
100. A. Fourati, M.V. El May, M. Ben Abdallah, A. Gamoudi, N. Mokni, and A. Goucha Prognostic evaluation of p53, heat shock protein 70, Ki67, and CD34 expression in cancer of the tongue in Tunisia J Otolaryngol Head Neck Surg 38 2 2009 191 196
101. M.A. Gonzalez-Moles, J.A. Gil-Montoya, I. Ruiz-Avila, F. Esteban, M. Delgado-Rodriguez, and A. Bascones-Martinez Prognostic significance of p21WAF1/CIP1, p16INK4a and CD44s in tongue cancer Oncol Rep 18 2 2007 389 396
102. M. Goto, T. Tsukamoto, K. Inada, T. Mizoshita, T. Ogawa, and A. Terada Loss of p21WAF1/CIP1 expression in invasive fronts of oral tongue squamous cell carcinomas is correlated with tumor progression and poor prognosis Oncol Rep 14 4 2005 837 846
103. R.A. Kwong, L.H. Kalish, T.V. Nguyen, J.G. Kench, R.J. Bova, and I.E. Cole P14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue Clin Cancer Res 11 11 2005 4107 4116
104. X. Xie P. CO, M.B. Prognostic significance of p21WAF1/CIP1 expression in tongue squamous cell carcinomas Arch Otolaryngol Head Neck Surg 128 8 2002 897 902
105. M.A. Gonzalez-Moles, I. Ruiz-Avila, J.A. Martinez, J.A. Gil-Montoya, F. Esteban, and S. Gonzalez-Moles P21WAF1/CIP1 protein and tongue cancer prognosis Anticancer Res 24 5B 2004 3225 3231
106. H. Mineta, K. Miura, I. Suzuki, S. Takebayashi, H. Amano, and K. Araki Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma Cancer 85 5 1999 1011 1017
107. K. Yoshizawa, S. Nozaki, A. Okamune, H. Kitahara, T. Ohara, and K. Kato Loss of maspin is a negative prognostic factor for invasion and metastasis in oral squamous cell carcinoma J Oral Pathol Med 38 6 2009 535 539
108. R. Yasumatsu, T. Nakashima, N. Hirakawa, Y. Kumamoto, Y. Kuratomi, and K. Tomita Maspin expression in stage I and II oral tongue squamous cell carcinoma Head Neck 23 11 2001 962 966
109. J.H. Cho, H.S. Kim, C.S. Park, J.K. Kim, K.Y. Jung, and B.K. Shin Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF) Oral Oncol 43 3 2007 272 277
110. K.C. Keum, E.J. Chung, W.S. Koom, J.H. Cho, S.H. Cho, and E.C. Choi Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer Otolaryngol Head Neck Surg 135 6 2006 858 864
111. A. Högmo, A.L. Borresen-Dale, H. Blegen, J. Lindholm, R. Kuylenstierna, and G. Auer TP53 mutations do not correlate with locoregional recurrence in stage I tongue carcinomas Anticancer Research 19 4C 1999 3433 3438
112. I.O. Bello, S.T. Vilen, A. Niinimaa, S. Kantola, Y. Soini, and T. Salo Expression of claudins 1,4,5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue Hum Pathol 39 8 2008 1212 1220
113. A. Kurokawa, M. Nagata, N. Kitamura, A.A. Noman, M. Ohnishi, and T. Ohyama Diagnostic value of integrin alpha 3, beta 4, and beta 5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma Cancer 112 6 2008 1272 1281
114. H.W. Chang, V. Chow, K.Y. Lam, W.I. Wei, and A. Yuen Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance Cancer 94 2 2002 386 392
115. V. Chow, A.P. Yuen, K.Y. Lam, G.S. Tsao, W.K. Ho, and W.I. Wei A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma J Cancer Res Clin Oncol 127 1 2001 59 63
116. S. Li, J. Jiao, Z. Lu, and M. Zhang An essential role for N-cadherin and beta-catenin for progression in tongue squamous cell carcinoma and their effect on invasion and metastasis of Tca8113 tongue cancer cells Oncol Rep 21 5 2009 1223 1233
117. S. Sato, M. Miyauchi, T. Takekoshi, M. Zhao, Y. Kudo, and I. Ogawa Reduced expression of CD44 variant 9 is related to lymph node metastasis and poor survival in squamous cell carcinoma of tongue Oral Oncol 36 6 2000 545 549
118. M. Masuda, Y. Kuratomi, H. Shiratsuchi, T. Nakashima, K. Naonobu, and S. Komiyama Decreased CD44H expression in early-stage tongue carcinoma associates with late nodal metastases following interstitial brachytherapy Head Neck 22 7 2000 662 665
119. S. Yanamoto, G. Kawasaki, I. Yoshitomi, T. Iwamoto, K. Hirata, and A. Mizuno Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy Oral Oncol 43 9 2007 869 877
120. K. Kawano, and S. Yanagisawa Predictive value of laminin-5 and membrane type 1-matrix metalloproteinase expression for cervical lymph node metastasis in T1 and T2 squamous cell carcinomas of the tongue and floor of the mouth Head Neck 28 6 2006 525 533
121. T. Yoshizaki, Y. Maruyama, H. Sato, and M. Furukawa Expression of tissue inhibitor of matrix metalloproteinase-2 correlates with activation of matrix metalloproteinase-2 and predicts poor prognosis in tongue squamous cell carcinoma Int J Cancer 95 1 2001 44 50
122. S.H. Kim, N.H. Cho, K. Kim, J.S. Lee, B.S. Koo, and J.H. Kim Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression J Surg Oncol 93 4 2006 330 337
123. D. Guttman, Y. Stern, T. Shpitzer, D. Ulanovski, T. Druzd, and R. Feinmesser Expression of MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell carcinoma of the tongue Oral Oncol 40 8 2004 798 803
124. H. Mineta, K. Miura, T. Ogino, S. Takebayashi, K. Misawa, and Y. Ueda Vascular endothelial growth factor (VEGF) expression correlates with p53 and ki-67 expressions in tongue squamous cell carcinoma Anticancer Res 22 2B 2002 1039 1044
125. Y. Tanigaki, Y. Nagashima, Y. Kitamura, H. Matsuda, Y. Mikami, and M. Tsukuda The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma Int J Mol Med 14 3 2004 389 395
126. S.E. Faustino, D.T. Oliveira, S. Nonogaki, G. Landman, A.L. Carvalho, and L.P. Kowalski Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma Int J Oral Maxillofac Surg 37 4 2008 372 378
127. S.S. Forootan, Y. Ke, A.S. Jones, and T.R. Helliwell Basic fibroblast growth factor and angiogenesis in squamous carcinoma of the tongue Oral Oncol 36 5 2000 437 443
128. X. Xie, O.P. Clausen, and M. Boysen Bag-1 expression as a prognostic factor in tongue squamous cell carcinomas Laryngoscope 114 10 2004 1785 1790
129. J.L. Roh, K.J. Cho, G.Y. Kwon, C.H. Ryu, H.W. Chang, and S.H. Choi The prognostic value of hypoxia markers in T2-staged oral tongue cancer Oral Oncol 45 1 2009 63 68
130. S.J. Kim, H.J. Shin, K.Y. Jung, S.K. Baek, B.K. Shin, and J. Choi Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue Jpn J Clin Oncol 37 11 2007 812 819
131. C. Gaggioli, S. Hooper, C. Hidalgo-Carcedo, R. Grosse, J.F. Marshall, and K. Harrington Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells Nat Cell Biol 9 12 2007 1392 1400